ORLANDO, Fla. — Food and Drug Administration advisors have voted to endorse an Alzheimer’s drug from Eli Lilly.
▶ WATCH CHANNEL 9 EYEWITNESS NEWS
The FDA panel agreed this week that the drug is safe and effective.
It’s a monoclonal antibody designed to slow the progression of early stages of Alzheimer’s disease.
If approved, this would be the second drug on the market with those intended effects.
Click here to download our free news, weather and smart TV apps. And click here to stream Channel 9 Eyewitness News live.
©2024 Cox Media Group
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/45O56QGEI5HMHEJF3U4GO2MWIE.jpeg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/IXWSXRHYKBELDM2U5ZVPTFF4QY.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/2HMLHIH3C5GTHJV6NUR37SB6YA.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/D6Y7QCD2N5GXXAICUX74H4W2DQ.jpeg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/7BQFUGK5HNGIDIANC3CANNREKY.jpg)